Eli Lilly and Novo Nordisk are ahead in manufacturing but need time to meet demand, says Louise Chen

Louise Chen, Cantor Fitzgerald analyst, joins CNBC’s ‘Squawk Box’ to discuss Eli Lilly’s surge over the past year, manufacturing, and more.